These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32010426)

  • 21. The role of microRNA in metastatic colorectal cancer and its significance in cancer prognosis and treatment.
    Tokarz P; Blasiak J
    Acta Biochim Pol; 2012; 59(4):467-74. PubMed ID: 23173124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro.
    Sun Z; Hu W; Xu J; Kaufmann AM; Albers AE
    Int J Oncol; 2015 Oct; 47(4):1339-50. PubMed ID: 26323460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. microRNA-320a inhibits tumor invasion by targeting neuropilin 1 and is associated with liver metastasis in colorectal cancer.
    Zhang Y; He X; Liu Y; Ye Y; Zhang H; He P; Zhang Q; Dong L; Liu Y; Dong J
    Oncol Rep; 2012 Mar; 27(3):685-94. PubMed ID: 22134529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miRNA-regulated delivery of lincRNA-p21 suppresses β-catenin signaling and tumorigenicity of colorectal cancer stem cells.
    Wang J; Lei ZJ; Guo Y; Wang T; Qin ZY; Xiao HL; Fan LL; Chen DF; Bian XW; Liu J; Wang B
    Oncotarget; 2015 Nov; 6(35):37852-70. PubMed ID: 26497997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-873 inhibits colorectal cancer metastasis by targeting ELK1 and STRN4.
    Fan C; Lin B; Huang Z; Cui D; Zhu M; Ma Z; Zhang Y; Liu F; Liu Y
    Oncotarget; 2019 Jun; 10(41):4192-4204. PubMed ID: 31289617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA expression patterns of tumors in early-onset colorectal cancer patients.
    Ak S; Tunca B; Tezcan G; Cecener G; Egeli U; Yilmazlar T; Ozturk E; Yerci O
    J Surg Res; 2014 Sep; 191(1):113-22. PubMed ID: 24746948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer.
    Feng C; Zhang L; Sun Y; Li X; Zhan L; Lou Y; Wang Y; Liu L; Zhang Y
    Biomed Pharmacother; 2018 May; 101():945-952. PubMed ID: 29635904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma miR-200c and miR-18a as potential biomarkers for the detection of colorectal carcinoma.
    Zhang GJ; Zhou T; Liu ZL; Tian HP; Xia SS
    Mol Clin Oncol; 2013 Mar; 1(2):379-384. PubMed ID: 24649179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer.
    Hur K; Toiyama Y; Okugawa Y; Ide S; Imaoka H; Boland CR; Goel A
    Gut; 2017 Apr; 66(4):654-665. PubMed ID: 26701878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Circulating miRNAs Expression Alterations in Matched Tissue and Plasma Samples During Colorectal Cancer Progression.
    Nagy ZB; Barták BK; Kalmár A; Galamb O; Wichmann B; Dank M; Igaz P; Tulassay Z; Molnár B
    Pathol Oncol Res; 2019 Jan; 25(1):97-105. PubMed ID: 28980150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
    Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
    Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stratifying risk of recurrence in stage II colorectal cancer using deregulated stromal and epithelial microRNAs.
    Bullock MD; Pickard K; Mitter R; Sayan AE; Primrose JN; Ivan C; Calin GA; Thomas GJ; Packham GK; Mirnezami AH
    Oncotarget; 2015 Mar; 6(9):7262-79. PubMed ID: 25788261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44.
    Yu G; Yao W; Xiao W; Li H; Xu H; Lang B
    J Exp Clin Cancer Res; 2014 Dec; 33(1):779. PubMed ID: 25551284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maintenance of the stemness in CD44(+) HCT-15 and HCT-116 human colon cancer cells requires miR-203 suppression.
    Ju SY; Chiou SH; Su Y
    Stem Cell Res; 2014 Jan; 12(1):86-100. PubMed ID: 24145190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-suppressive miR-26a and miR-26b inhibit cell aggressiveness by regulating FUT4 in colorectal cancer.
    Li Y; Sun Z; Liu B; Shan Y; Zhao L; Jia L
    Cell Death Dis; 2017 Jun; 8(6):e2892. PubMed ID: 28640257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between
    Proença MA; Biselli JM; Succi M; Severino FE; Berardinelli GN; Caetano A; Reis RM; Hughes DJ; Silva AE
    World J Gastroenterol; 2018 Dec; 24(47):5351-5365. PubMed ID: 30598580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA signatures: novel biomarker for colorectal cancer?
    Luo X; Burwinkel B; Tao S; Brenner H
    Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1272-86. PubMed ID: 21551242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA and targeted mRNA expression profiling analysis in human colorectal adenomas and adenocarcinomas.
    Gattolliat CH; Uguen A; Pesson M; Trillet K; Simon B; Doucet L; Robaszkiewicz M; Corcos L
    Eur J Cancer; 2015 Feb; 51(3):409-20. PubMed ID: 25586944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
    Shi L; Xi J; Xu X; Peng B; Zhang B
    Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer.
    Tsukamoto M; Iinuma H; Yagi T; Matsuda K; Hashiguchi Y
    Oncology; 2017; 92(6):360-370. PubMed ID: 28376502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.